Board Certified in Medical Oncology
Pleural and Lung Cancer
20+ Years of Experience
She is involved in experimental therapeutics of lung, head and neck cancers. Sabichi helped investigate a clinical trial involving bevacizumab in the treatment of head and neck cancers. Bevacizumab, also known by brand name Avastin, was recently added to the National Comprehensive Cancer Network’s first-line mesothelioma treatment recommendations.
Sabichi, who has been in practice for more than 20 years, graduated from the University of Colorado School of Medicine. She completed her residency at New York Presbyterian Hospital and her fellowship at the National Institutes of Health Clinical Center.See More Top Mesothelioma Doctors
Disclaimer: Dr. Anita Lyn Sabichi has no professional affiliation with Asbestos.com.
Share this article
Last Modified October 17, 2018
1 Cited Article Sources
- Baylor College of Medicine. (n.d.). Anita Lyn Sabichi, M.D. Retrieved from: https://www.bcm.edu/people/view/anita-sabichi-m-d/b24cba2b-ffed-11e2-be68-080027880ca6